Europe Blood and Blood Components Market to surpass $ 5 BN by 2025

February 21, 2020


As per the report titled ‘Europe Blood and Blood Components Market Size By Product (Whole Blood, Blood Components {Red Blood Cells, Platelets, Plasma, White Blood Cells}), By Application (Anemia, Trauma & Surgery, Cancer Treatment, Bleeding Disorders), By End-Use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Country Outlook (Germany, UK, France, Spain, Italy, Russia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024’ available with Market Study Report LLC, Europe blood and blood components market size is predicted to be pegged at a valuation of USD 5 billion by 2025.
 

According to the report, mounting cases of road accidents, surgical procedures, and trauma that require blood transfusion owing to the considerable amount of blood loss is likely to provide a profitable growth graph for Europe blood and blood components market. Additionally, burgeoning cosmetic surgeries would propel the need for blood components, potentially driving the market expansion.
 

Based on the product segmentation, report claims that blood components segment acquired a substantial revenue share of 70% in 2017 and is expected to grow at a prodigious pace in the upcoming years. The segmental growth is attributed to the use of blood components in vivid procedures including aesthetic surgeries, chemotherapy, and various other conditions like anemia, bleeding disorders, etc.
 

In terms of the application spectrum, cancer treatment segment is likely to garner hefty proceeds over the foreseeable period perhaps ascribing to the rising prevalence of various cancer forms. Blood components are used to counteract for low blood cell count, resulting into an increase in blood components usage. Furthermore, adoption of sedentary lifestyle across Europe has elevated the risk of cancer which is likely to augment the demand for blood components and positively impact the market dynamics.
 

As per the end-use landscape, report cites that ambulatory surgical center segment procured a business size of USD 1.5 billion in 2017 and is depicted to amass noteworthy gains over 2019-2025 due to focused care and relatively shorter procedural time offered by these settings. Moreover, expanding demand for surgical procedures in tandem with growing economic affluence will bolster the segmental growth.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2100695/
 

Considering the regional topography, Russia blood and blood components market is expected to develop at a rapid pace over the stipulated time period on account of growing number of blood donations in the region. Also, expanding geriatric population base and government initiatives to educate the citizens on blood donation will substantially aid the growth of Russia market by the end of 2025.
 

Europe blood and blood components market is highly consolidated and is characterized by the presence of few prominent associations across the region including NHS Blood and Transplant, Red Cross and Red Crescent Societies, Welsh Blood Services, and Northern Ireland Blood Transfusion Service among others. These associations are adopting strategic initiatives such as mergers, acquisitions, collaboration, and product launches to enhance their market presence across Europe.


Frequently Asked Questions (FAQ) :

According to the report, mounting cases of road accidents, surgical procedures, and trauma that require blood transfusion owing to the considerable amount of blood loss is likely to provide a profitable growth graph for Europe blood and blood components market. Additionally, burgeoning cosmetic surgeries would propel the need for blood components, potentially driving the market expansion.
Based on the product segmentation, report claims that blood components segment acquired a substantial revenue share of 70% in 2017 and is expected to grow at a prodigious pace in the upcoming years. The segmental growth is attributed to the use of blood components in vivid procedures including aesthetic surgeries, chemotherapy, and various other conditions like anemia, bleeding disorders, etc.
As per the end-use landscape, report cites that ambulatory surgical center segment procured a business size of USD 1.5 billion in 2017 and is depicted to amass noteworthy gains over 2019-2025 due to focused care and relatively shorter procedural time offered by these settings. Moreover, expanding demand for surgical procedures in tandem with growing economic affluence will bolster the segmental growth.
Europe blood and blood components market is highly consolidated and is characterized by the presence of few prominent associations across the region including NHS Blood and Transplant, Red Cross and Red Crescent Societies, Welsh Blood Services, and Northern Ireland Blood Transfusion Service, amongst multiple others. These associations are adopting strategic initiatives such as mergers, acquisitions, collaboration, and product launches to enhance their market presence across Europe.